PD03: Prostate Cancer: Epidemiology & Natural History I

Room 245
Podium
Oncology: Prostate

Information

Format
In PersonOn Demand

PD03: Prostate Cancer: Epidemiology & Natural History I

PD03-01: MRI as first investigation in men with elevated PSA. Population-based cohort study

Friday, May 13, 2022 7:00 AM to 7:10 AM
Room 245
David Robinsson · Highland Hospital

PD03-02: Long-Term Effects of 5&[alpha]-Reductase Inhibitors on Prostate Cancer Mortality - a Large Population-Based Prospective Study

Friday, May 13, 2022 7:10 AM to 7:20 AM
Room 245
Lars Bjornebo · Karolinska Institute

PD03-03: Association between 5&[alpha]-reductase Inhibitor and Incidence, Tumor Grading and Survival of Prostate Cancer

Friday, May 13, 2022 7:20 AM to 7:30 AM
Room 245
PengYen Wu · Taichung Veterans General Hospital

PD03-04: Systematic review of the impact of a plant-based diet on prostate cancer incidence and outcomes

Friday, May 13, 2022 7:30 AM to 7:40 AM
Room 245
Natasha Gupta · NYU Langone Health

PD03-05: Prognostic Value of Lymph Node Count versus Lymph Node Density for Men with Pathological Node-Positive Prostate Cancer

Friday, May 13, 2022 7:40 AM to 7:50 AM
Room 245
Aurash Naser-Tavakolian · Cedars-Sinai Medical Center

PD03-06: Grade Migration of Prostate Cancer at Diagnosis Following the US Preventive Services Task Force Recommendations on Prostate Cancer Screening

Friday, May 13, 2022 7:50 AM to 8:00 AM
Room 245
Leonardo Borregales · Weill Cornell Medicine

PD03-07: Association Between Adverse Surgical Pathology and Overall Survival Among Patients with Low-Risk Prostate Cancer

Friday, May 13, 2022 8:00 AM to 8:10 AM
Room 245
Eileen Lee · Rutgers Robert Wood Johnson

PD03-08: The Impact of Medicaid Expansion on Insurance Coverage and Metastatic Disease at Diagnosis in Prostate Cancer Patients

Friday, May 13, 2022 8:10 AM to 8:20 AM
Room 245
David Schroeder

PD03-09: The Natural History of a Detectable Serum PSA after Radical Prostatectomy

Friday, May 13, 2022 8:20 AM to 8:30 AM
Room 245
Julie A. Szymaniak

PD03-10: Effect of Advances in Treatment on Population-level Survival of Patients with Metastatic Prostate Cancer

Friday, May 13, 2022 8:30 AM to 8:40 AM
Room 245
Camilo Arenas Gallo · Case Western Reserve University

PD03-11: Patient-reported delays in treatment for urologic cancers during the Covid-19 pandemic: A national cross-sectional analysis

Friday, May 13, 2022 8:40 AM to 8:50 AM
Room 245
Jacob Lang · University of Toledo College of Medicine

PD03-12: Covid-19 disruption to prostate cancer management in a UK tertiary referral centre

Friday, May 13, 2022 8:50 AM to 9:00 AM
Room 245
Nithesh Ranasinha · Oxford University

Registered attendees

Jann Amery Abrenica
Jann Amery Abrenica
NP, RNSt. Joseph's Medical Center
DA
Daniel Amici
PA-CUrology Associates of Denver
Mark Oliver Christian Sebastian Amponin
Mark Oliver Christian Sebastian Amponin
Urologist